The MRZ reaction has been proposed as a highly specific (rule-in rather than rule-out) marker of MS[40, 41], which discriminates well between MS and neuromyelitis optica [42, 43] and possibly also between MS and MOG encephalomyelitis [44]. The gene discussed is MOG; the disease is myeloid sarcoma.